Micromeritics’ Solutions Identify and Control Critical Quality Attributes
Quality by design (QbD) is a developmental approach, which predefines objectives and emphasises understanding of product s and process control from science and quality risk management.
Achieving QbD requires an in depth understanding of psychochemical properties, which predict processability, in vivo, and in vitrio performance. Early identification of critical quality attributes (CQA) of excipients and active pharmaceutical ingredients (API) and their impact on a formulation is a key component of QbD.
Micromeritics’ Instruments and contract analytical services offers solutions for the early identification of CQAs, continuous process monitoring, and verification, which are the foundations of QbD.
Download to find out more.